TrialToxins2020

Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature.

Sara Samadzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.